Tucatinib 150mg Tablets are an advanced targeted therapy used in the treatment of HER2-positive breast cancer, particularly in patients with advanced or metastatic conditions. Cordium Pharmaceuticals Pvt Ltd, a trusted global exporter based in India, ensures high-quality supply with fast and reliable delivery to countries including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
What is Tucatinib 150mg?
Tucatinib is a tyrosine kinase inhibitor specifically designed to target the HER2 protein, helping to slow down or stop the growth of cancer cells. It is often prescribed in combination with other medications such as trastuzumab and capecitabine for enhanced effectiveness.
Usage:
Tucatinib 150mg Tablets are primarily used for:
- Treatment of HER2-positive metastatic breast cancer
- Patients who have received prior anti-HER2-based regimens
- Combination therapy with other cancer medications
Dosage:
- The typical recommended dosage is 300 mg taken orally twice daily (two 150 mg tablets per dose).
- Tablets should be swallowed whole with water, with or without food.
- Dosage adjustments may be required based on patient condition and doctor’s recommendation.
- Always follow the prescription provided by a healthcare professional.
Side Effects:
Like all medications, Tucatinib may cause some side effects, including:
- Diarrhea
- Fatigue
- Nausea and vomiting
- Liver enzyme abnormalities
- Decreased appetite
- Hand-foot syndrome
If severe side effects occur, immediate medical attention is advised.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
- Reliable global exporter from India
- High-quality pharmaceutical products
- Competitive pricing
- Fast and secure international delivery
- Professional customer support
Global Shipping Available:
We deliver Tucatinib 150mg Tablets across:
United States | Germany | United Kingdom | Netherlands | South Africa | United Arab Emirates | Brazil
Contact Us Today:
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
